Low IL-13Rα1 expression on mast cells tunes them unresponsive to IL-13
Journal of Leukocyte Biology · 2023
DOI: 10.1093/jleuko/qiad065 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Leukocyte Biology, 2023. Verfasst von Tanja Salomaa und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and Health Technology, Tampere University, 33014 Tampere, Finland. Hauptthemen laut MEDLINE: Interleukin-13, Interleukin-4. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Academy of Finland, Competitive State Research Financing of the Expert Responsibility Area of Fimlab Laboratories, Competitive State Research Financing of the Expert Responsibility Area of Tampere University Hospital.
Abstract (Originalsprache)
Cytokine-mediated mast cell regulation enables precise optimization of their own proinflammatory cytokine production. During allergic inflammation, interleukin (IL)-4 regulates mast cell functions, tissue homing, and proliferation, but the direct role of closely related IL-13 for mast cell activation remains unclear. Previous work has shown that mast cells are potent IL-13 producers, but here we show that mouse mast cells do not directly respond to IL-13 by Stat6 activation, as they do not express measurable amount of IL-13 receptor α1 (IL-4Rα1) messenger RNA. Consequently, IL-4 responses are mediated via type I IL-4R (IL-4/IL4Rα/γC), and IL-4–induced Stat6 activation is abolished in γC-deficient mast cells. Type II IL-4R deficiency (IL-13Rα1 knockout) has no effect on IL-4–induced Stat6 activation. In basophils, both IL-4 and IL-13 induce Stat6 activation in wild-type and γC-deficient cells, while in type II IL-4R–deficient basophils, IL-4 signaling is impaired at low ligand concentration. Thus, mast cell and basophil sensitivity to IL-4/IL-13 is different, and in mast cells, lack of IL-13Rα1 expression likely explains their unresponsiveness to IL-13.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine and Health Technology, Tampere University, 33014 Tampere, Finland.
- Fimlab Laboratories, 33520 Tampere, Finland.
- Northern Finland Laboratory Centre (NordLab), 90220 Oulu, Finland.
- Department of Orthopaedics and Traumatology, Tampere University Hospital, 33520 Tampere, Finland.
- Research Unit of Biomedicine, University of Oulu, 90570 Oulu, Finland.
ORCID-Profile: Ilkka S Junttila
Förderung
- Academy of Finland
- Competitive State Research Financing of the Expert Responsibility Area of Fimlab Laboratories
- Competitive State Research Financing of the Expert Responsibility Area of Tampere University Hospital
- Tampere University Hospital Support Foundation
- Tampere Tuberculosis Foundation
- Päivikki and Sakari Sohlberg Foundation
- T.A.H.J.
- Orion Research Foundation
Zitieren
APA
Salomaa, T., Kummola, L., González-Rodríguez, M. I., Hiihtola, L., Järvinen, T. A. H., & Junttila, I. S. (2023). Low IL-13Rα1 expression on mast cells tunes them unresponsive to IL-13. Journal of Leukocyte Biology. https://doi.org/10.1093/jleuko/qiad065
Vancouver
Salomaa T, Kummola L, González-Rodríguez MI, Hiihtola L, Järvinen TAH, Junttila IS. Low IL-13Rα1 expression on mast cells tunes them unresponsive to IL-13. Journal of Leukocyte Biology. 2023. doi:10.1093/jleuko/qiad065
BibTeX
@article{Salomaa2023,
author = {Salomaa, Tanja and Kummola, Laura and González-Rodríguez, Martín Ignacio and Hiihtola, Lotta and Järvinen, Tero A H and Junttila, Ilkka S},
title = {Low IL-13Rα1 expression on mast cells tunes them unresponsive to IL-13},
journal = {Journal of Leukocyte Biology},
year = {2023},
doi = {10.1093/jleuko/qiad065}
}
EUVIMED